Brought to you by 
Hologic offers $580mm cash for Third Wave Technologies
08 Sep 2008
Executive Summary
Only a year after bulking up women's health offerings through its Cytyc merger and BioLucent takeover, diagnostic imaging player Hologic is acquiring another company in this space--publicly held Third Wave Technologies (TWT; molecular diagnostics) for $580mm in cash.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hologic offers $580mm cash for Third Wave Technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice